Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine

Vaccine

Volumn 29, Issue 32, 2011, Pages 5276-5283

  Carmichael, Jennifer R ^a   Pal, Sukumar ^a   Tifrea, Delia ^a   De la Maza, Luis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia; Immunization; Infertility; Mice; Mucosal; RMOMP

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; MONTANIDE ISA 51; OUTER MEMBRANE PROTEIN; PORIN; PORIN B; RECOMBINANT CHLAMYDIA VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CHLAMYDIA; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; FEMALE INFERTILITY; HUMORAL IMMUNITY; IMMUNIZATION; INOCULATION; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VAGINA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFERTILITY; MANNITOL; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; NEISSERIA GONORRHOEAE; OLEIC ACIDS; VACCINES, SYNTHETIC; VAGINA;

EID: 79960325511     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.013     Document Type: Article

References (54)

1. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009, 58(April (14)):362-365.
2. Miller W.C., Ford C.A., Morris M., Handcock M.S., Schmitz J.L., Hobbs M.M., et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004, 291(May (18)):2229-2236.
3. Schachter J., Dawson C. Human chlamydial infections 1978, PSG Publishing Co., Littleton.
4. Stamm W. Chlamydia trachomatis infections of the adult. Sexually transmitted diseases 2008, 575-593. McGrawHill Book Co., New York. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.W. Wasserheit, L. Corey, M.S. Cohen, D.H. Watts (Eds.).
5. Miyairi I., Ramsey K.H., Patton D.L. Duration of untreated chlamydial genital infection and factors associated with clearance: review of animal studies. J Infect Dis 2010, 201(June (Suppl. 2)):S96-S103.
6. Westrom L., Joesoef R., Reynolds G., Hagdu A., Thompson S.E. Pelvic inflammatory disease and fertility: a cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992, 19(July-August (4)):185-192.
7. Wang S.P., Grayston J.T., Alexander E.R. Trachoma vaccine studies in monkeys. Am J Ophthalmol 1967, 63(May (5 Suppl.)):1615-1630.
8. Grayston J.T., Wang S. New knowledge of chlamydiae and the diseases they cause. J Infect Dis 1975, 132(July (1)):87-105.
9. Grayston J.T., Wang S.P. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis 1978, 5(April-June (2)):73-77.
10. Morrison R.P., Caldwell H.D. Immunity to murine chlamydial genital infection. Infect Immun 2002, 70(June (6)):2741-2751.
11. de la Maza L.M., Peterson E.M. Vaccines for Chlamydia trachomatis infections. Curr Opin Investig Drugs 2002, 3(July (7)):980-986.
12. Baehr W., Zhang Y.X., Joseph T., Su H., Nano F.E., Everett K.D., et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA 1988, 85(June (11)):4000-4004.
13. Ortiz L., Demick K.P., Petersen J.W., Polka M., Rudersdorf R.A., Van der Pol B., et al. Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J Immunol 1996, 157(November (10)):4554-4567.
14. Kari L., Whitmire W.M., Crane D.D., Reveneau N., Carlson J.H., Goheen M.M., et al. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J Immunol 2009, 182(June (12)):8063-8070.
15. Pal S., Peterson E.M., de la Maza L.M. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 2005, 73(December (12)):8153-8160.
16. Pal S., Davis H.L., Peterson E.M., de la Maza L.M. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge. Infect Immun 2002, 70(September (9)):4812-4817.
17. Sun G., Pal S., Weiland J., Peterson E.M., de la Maza L.M. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Vaccine 2009, 27(August (36)):5020-5025.
18. de la Maza M.A., de la Maza L.M. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 1995, 13(January (1)):119-127.
19. Nigg C. An unidentified virus which produces pneumonia and systemic infection in mice. Science 1942, 95(January (2454)):49-50.
20. Pal S., Fielder T.J., Peterson E.M., de la Maza L.M. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1994, 62(August (8)):3354-3362.
21. Caldwell H.D., Kromhout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981, 31(March (3)):1161-1176.
22. Fielder T.J., Pal S., Peterson E.M., de la Maza L.M. Sequence of the gene encoding the major outer membrane protein of the mouse pneumonitis biovar of Chlamydia trachomatis. Gene 1991, 106(September (1)):137-138.
23. Marston F.A. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem J 1986, 240(November (1)):1-12.
24. Qi H.L., Tai J.Y., Blake M.S. Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers. Infect Immun 1994, 62(June (6)):2432-2439.
25. Amorij J.P., Westra T.A., Hinrichs W.L., Huckriede A., Frijlink H.W. Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model. Vaccine 2007, 26(December (1)):67-76.
26. McConnell E.L., Basit A.W., Murdan S. Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration. Vaccine 2008, 26(January (5)):639-646.
27. Cuburu N., Kweon M.N., Song J.H., Hervouet C., Luci C., Sun J.B., et al. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 2007, 25(December (51)):8598-8610.
28. Tuffrey M., Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 1981, 12:111-115.
29. Peterson E.M., Zhong G.M., Carlson E., de la Maza L.M. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun 1988, 56(April (4)):885-891.
30. Hansen J., Jensen K.T., Follmann F., Agger E.M., Theisen M., Andersen P. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model. J Infect Dis 2008, 198(September (5)):758-767.
31. Hickey D.K., Aldwell F.E., Beagley K.W. Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection. Vaccine 2010, 28(February (7)):1668-1672.
32. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11(April (4 Suppl.)):S45-S53.
33. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007, 25(July (30)):5467-5484.
34. Vajdy M., Baudner B., Del Giudice G., O'Hagan D. A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza. Clin Immunol 2007, 123:166-175.
35. Asanuma H., Aizawa C., Kurata T., Tamura S. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. Vaccine 1998, 16(August (13)):1257-1262.
36. Srivastava I., Goodsell A., Zhou F., Sun Y., Burke B., Barnett S., et al. Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes. Vaccine 2008, 26:2796-2806.
37. Vajdy M., Singh M., Ugozzoli M., Briones M., Soenawan E., Cuadra L., et al. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting. Immunology 2003, 10:86-94.
38. Herremans T.M., Reimerink J.H., Buisman A.M., Kimman T.G., Koopmans M.P. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J Immunol 1999, 162:5011-5018.
39. Stevceva L., Strober W. Mucosal HIV vaccines: where are we now?. Curr HIV Res 2004, 2(January (1)):1-10.
40. Wassen L., Schon K., Holmgren J., Jertborn M., Lycke N. Local intravaginal vaccination of the female genital tract. Scand J Immunol 1996, 44(October (4)):408-414.
41. Parr E.L., Parr M.B., Thapar M. A comparison of specific antibody responses in mouse vaginal fluid after immunization by several routes. J Reprod Immunol 1988, 14(November (2)):165-176.
42. Thapar M.A., Parr E.L., Bozzola J.J., Parr M.B. Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). Vaccine 1991, 9(February (2)):129-133.
43. Montgomery P.C., Rafferty D.E. Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles. Oral Microbiol Immunol 1998, 13(June (3)):139-149.
44. BenMohamed L., Belkaid Y., Loing E., Brahimi K., Gras-Masse H., Druilhe P. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur J Immunol 2002, 32(August (8)):2274-2281.
45. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350(February (9)):896-903.
46. van Ginkel F.W., Jackson R.J., Yuki Y., McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 2000, 165(November (9)):4778-4782.
47. Abel K., Rourke T., Lu D., Bost K., McChesney M.B., Miller C.J. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J Infect Dis 2004, 190(November (9)):1697-1705.
48. Kaushic C., Ashkar A.A., Reid L.A., Rosenthal K.L. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 2003, 77(April (8)):4558-4565.
49. Kaushic C., Zhou F., Murdin A.D., Wira C.R. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect Immun 2000, 68(July (7)):4207-4216.
50. Edwards J.L. Neisseria gonorrhoeae survival during primary human cervical epithelial cell infection requires nitric oxide and is augmented by progesterone. Infect Immun 2010, 78(March (3)):1202-1213.
51. Morrison R.P., Feilzer K., Tumas D.B. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995, 63(December (12)):4661-4668.
52. Shah A.A., Schripsema J.H., Imtiaz M.T., Sigar I.M., Kasimos J., Matos P.G., et al. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 2005, 32(January (1)):49-56.
53. Gillgrass A.E., Ashkar A.A., Rosenthal K.L., Kaushic C. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol 2003, 77(September (18)):9845-9851.
54. de la Maza L.M., Pal S., Khamesipour A., Peterson E.M. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994, 62(May (5)):2094-2097.